GL1X · GenesisL1 explorer

MolNFT v1 · #32786 · protein

Non-aged form of mouse acetylcholinesterase inhibited by tabun

2C0Q: “Non-aged form of mouse acetylcholinesterase inhibited by tabun”. X-ray diffraction, 1 ligand (NTJ), 13 pockets (best druggability 0.75). MolNFT v1 #32786 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2C0Q
Type
protein
Length
1,068 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Acetylcholinesterase
EC
3.1.1.7
UniProt
P21836
Ligands
NTJ
Pockets
13 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAcetylcholinesterase (EC 3.1.1.7)protein53538% helix, 18% strandP21836
BAcetylcholinesterase (EC 3.1.1.7)protein53338% helix, 18% strandP21836

Ligands and binding sites

  • NTJ · R-ethyl N,N-dimethylphosphonamidate · ligand · 2 copies · chains A, B
  • P6G · Hexaethylene glycol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12730.750.8836NTJ
22470.750.8834NTJ
32530.630.8134P6G
43440.620.7832empty
53160.600.7832empty

Interfaces

1 interface between chains.

  • A–B · 995 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 covalent (disulfide, covalent ligand).

Compared structures

  • 2C0Q · non-aged form of mouse acetylcholinesterase inhibited by tabun · the same entry in another collection · chain A against A, TM-score 1.00
  • P21836 · AlphaFold monomer V2.0 prediction for acetylcholinesterase (P21836) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.